<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; Research Projects</title>
	<atom:link href="http://www.bioscreening.net/category/industry-trends/research-projects/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Four anti-cancer compounds identified</title>
		<link>http://www.bioscreening.net/2011/12/02/four-anti-cancer-compounds-identified/</link>
		<comments>http://www.bioscreening.net/2011/12/02/four-anti-cancer-compounds-identified/#comments</comments>
		<pubDate>Fri, 02 Dec 2011 16:38:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1363</guid>
		<description><![CDATA[Sydney: Four new anti-cancer compounds have shown promise in inhibiting the growth of tumours, according to a new approach. Jason Smith, doing his M.Phil. in biomolecular sciences from Macquarie University, combined existing knowledge of an enzyme with computational chemistry approach to identify novel (cancer) inhibitors. The enzyme (indoleamine 2,3-dioxygenase) has generated excitement amongst researchers due [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/12/02/four-anti-cancer-compounds-identified/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NMR Fine-Tuned for High-Content Metabolomics Screening</title>
		<link>http://www.bioscreening.net/2011/11/28/nmr-fine-tuned-for-high-content-metabolomics-screening/</link>
		<comments>http://www.bioscreening.net/2011/11/28/nmr-fine-tuned-for-high-content-metabolomics-screening/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 17:48:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1350</guid>
		<description><![CDATA[Scientists report on the development of a nuclear magnetic resonance (NMR)-based method forscreening the metabolomic response of drug-treated mammalian cells to drug therapy. TheSanford-Burnham Medical Research Institute, and Rady Children’s Hospital investigators, say the highly sensitive, fast, and simple method is carried out in 96-well format, and could have particular utility as a method for high-throughput [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/28/nmr-fine-tuned-for-high-content-metabolomics-screening/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Research at A&amp;M and Scripps finds HIV-killing compound</title>
		<link>http://www.bioscreening.net/2011/11/28/research-at-am-and-scripps-finds-hiv-killing-compound/</link>
		<comments>http://www.bioscreening.net/2011/11/28/research-at-am-and-scripps-finds-hiv-killing-compound/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 17:35:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1348</guid>
		<description><![CDATA[COLLEGE STATION - A powerful topical preventative for HIV, the virus that causes AIDS, could be a step closer to clinical trials, thanks to a newly discovered molecular compound that research at Texas A&#38;M University and the Scripps Research Institute shows dissolves the virus on contact. The ability of the synthetic compound known as &#8220;PD 404,182&#8243; [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/28/research-at-am-and-scripps-finds-hiv-killing-compound/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First Clinical Trial of Autologous Cardiac Stem Cells Shows Positive Results</title>
		<link>http://www.bioscreening.net/2011/11/22/first-clinical-trial-of-autologous-cardiac-stem-cells-shows-positive-results-2/</link>
		<comments>http://www.bioscreening.net/2011/11/22/first-clinical-trial-of-autologous-cardiac-stem-cells-shows-positive-results-2/#comments</comments>
		<pubDate>Tue, 22 Nov 2011 19:13:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[Stem Cell Research]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1345</guid>
		<description><![CDATA[Initial data from the first ever trial to evaluate autologous cardiac stem cell (CSC) transplants in humans suggests that the treatment improves left ventricular (LV) systolic function by an average of 12% over one year, and reduces infarct size in patients with severe heart failure due to ischemic heart disease. The trial investigators say the results triple the 4% [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/11/22/first-clinical-trial-of-autologous-cardiac-stem-cells-shows-positive-results-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Coffee Drinking Linked To Lower Risk Of Common Skin Cancer</title>
		<link>http://www.bioscreening.net/2011/10/25/coffee-drinking-linked-to-lower-risk-of-common-skin-cancer/</link>
		<comments>http://www.bioscreening.net/2011/10/25/coffee-drinking-linked-to-lower-risk-of-common-skin-cancer/#comments</comments>
		<pubDate>Tue, 25 Oct 2011 15:19:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1307</guid>
		<description><![CDATA[New research presented at a conference in the US on Monday finds that drinking coffee is linked to a lower risk of a common form of skin cancer known as basal cell carcinoma (BCC). Results of a prospective study that followed over 25,000 cases of skin cancer suggest coffee may be an important dietary option [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/10/25/coffee-drinking-linked-to-lower-risk-of-common-skin-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>X-Body BioSciences and Tanabe Research Labs Team Up to Develop mAbs for Autoimmune Diseases</title>
		<link>http://www.bioscreening.net/2011/10/04/x-body-biosciences-and-tanabe-research-labs-team-up-to-develop-mabs-for-autoimmune-diseases/</link>
		<comments>http://www.bioscreening.net/2011/10/04/x-body-biosciences-and-tanabe-research-labs-team-up-to-develop-mabs-for-autoimmune-diseases/#comments</comments>
		<pubDate>Tue, 04 Oct 2011 16:18:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1302</guid>
		<description><![CDATA[X-Body Biosciences entered a partnership with Tanabe Research Laboratories (TRL) to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies against those targets. TRL is focussed on discovery and development of biologicals for autoimmune diseases. Under terms of the deal, X-Body will be responsible for screening, and TRL will fund the work. TRL has [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/10/04/x-body-biosciences-and-tanabe-research-labs-team-up-to-develop-mabs-for-autoimmune-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists Use Mutant Protein to Inhibit Cancer Stem Cells and Resensitize Tumors to Lapatinib</title>
		<link>http://www.bioscreening.net/2011/09/14/scientists-use-mutant-protein-to-inhibit-cancer-stem-cells-and-resensitize-tumors-to-lapatinib/</link>
		<comments>http://www.bioscreening.net/2011/09/14/scientists-use-mutant-protein-to-inhibit-cancer-stem-cells-and-resensitize-tumors-to-lapatinib/#comments</comments>
		<pubDate>Wed, 14 Sep 2011 17:56:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[Stem Cell Research]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1292</guid>
		<description><![CDATA[Blocking a cancer cell protein from binding to three other proteins may provide a new approach to cancer therapy that both reduces populations of breast cancer initiating cells (BCICs) in breast tumors and sensitizes the tumors to existing treatments such as lapatinib or paclitaxel, scientists claim. The technique uses a specially designed lipid-based vector to [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/09/14/scientists-use-mutant-protein-to-inhibit-cancer-stem-cells-and-resensitize-tumors-to-lapatinib/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Insulin May Help Treat Alzheimer&#8217;s</title>
		<link>http://www.bioscreening.net/2011/09/14/insulin-may-help-treat-alzheimers/</link>
		<comments>http://www.bioscreening.net/2011/09/14/insulin-may-help-treat-alzheimers/#comments</comments>
		<pubDate>Wed, 14 Sep 2011 17:54:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1290</guid>
		<description><![CDATA[Researchers are investigating insulin as a possible treatment for Alzheimer&#8217;s disease, and in a preliminary study, the results look promising.A study in the journal Archives of Neurology suggests that intranasal insulin &#8211; that is, delivered through the nose &#8211; may help with cognition and functioning in patients who have both mild and more severe dementia.It&#8217;s [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/09/14/insulin-may-help-treat-alzheimers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ark to Manufacture PsiOxus’ IV-Administered Oncolytic Virus for Clinical Trials</title>
		<link>http://www.bioscreening.net/2011/09/12/ark-to-manufacture-psioxus%e2%80%99-iv-administered-oncolytic-virus-for-clinical-trials/</link>
		<comments>http://www.bioscreening.net/2011/09/12/ark-to-manufacture-psioxus%e2%80%99-iv-administered-oncolytic-virus-for-clinical-trials/#comments</comments>
		<pubDate>Mon, 12 Sep 2011 20:06:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1282</guid>
		<description><![CDATA[Ark Therapeutics negotiated a manufacturing partnership with PsiOxus Therapeutics for the latter’s ColoAd1 candidate for the treatment of colorectal cancer. Under terms of the agreement Ark will work with PsiOxus to generate an IV formulation of the adenovirus-based oncolytic product using its suspension-based single-use system (ATOSUS) for toxicological and Phase I/II clinical studies. ColoAd1 is [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/09/12/ark-to-manufacture-psioxus%e2%80%99-iv-administered-oncolytic-virus-for-clinical-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical Successes and New Technologies Revive Gene Therapy</title>
		<link>http://www.bioscreening.net/2011/09/09/clinical-successes-and-new-technologies-revive-gene-therapy/</link>
		<comments>http://www.bioscreening.net/2011/09/09/clinical-successes-and-new-technologies-revive-gene-therapy/#comments</comments>
		<pubDate>Fri, 09 Sep 2011 16:48:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1279</guid>
		<description><![CDATA[The prospect of curing human diseases by replacing a disease-related gene with a normal version remains the ultimate goal of gene therapy. But in its early days, attempts at gene therapy met with unpredictable and occasionally fatal outcomes. The field sustained a serious setback in 2000 following the death of 18-year old Jesse Gelsinger after [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/09/09/clinical-successes-and-new-technologies-revive-gene-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Canadian-made virus shows promise as cancer treatment</title>
		<link>http://www.bioscreening.net/2011/08/31/canadian-made-virus-shows-promise-as-cancer-treatment/</link>
		<comments>http://www.bioscreening.net/2011/08/31/canadian-made-virus-shows-promise-as-cancer-treatment/#comments</comments>
		<pubDate>Wed, 31 Aug 2011 20:32:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1272</guid>
		<description><![CDATA[An Ottawa-based research team has developed a virus that is showing promise as a new way of attacking and shrinking cancer tumours while leaving healthy tissue alone. It&#8217;s early days in the still-experimental field of therapeutic cancer viruses, called oncolytic viruses. But this new study from researchers from the Ottawa Hospital Research Institute (OHRI) and the [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/31/canadian-made-virus-shows-promise-as-cancer-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Adding caffeine to sunscreen could guard against skin cancer</title>
		<link>http://www.bioscreening.net/2011/08/18/adding-caffeine-to-sunscreen-could-guard-against-skin-cancer/</link>
		<comments>http://www.bioscreening.net/2011/08/18/adding-caffeine-to-sunscreen-could-guard-against-skin-cancer/#comments</comments>
		<pubDate>Thu, 18 Aug 2011 16:18:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1257</guid>
		<description><![CDATA[Scientists have worked out how caffeine might protect against certain skin cancers – a finding that could lead to better sunscreens. The research, conducted in mice, suggests that caffeine changes the activity of a gene involved in the destruction of cells that have DNA damage and are therefore more likely to become cancerous. The scientists [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/18/adding-caffeine-to-sunscreen-could-guard-against-skin-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Suicide-Bombing Bacteria Could Fight Infections</title>
		<link>http://www.bioscreening.net/2011/08/16/suicide-bombing-bacteria-could-fight-infections/</link>
		<comments>http://www.bioscreening.net/2011/08/16/suicide-bombing-bacteria-could-fight-infections/#comments</comments>
		<pubDate>Tue, 16 Aug 2011 18:38:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[RNA Reasearch]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1248</guid>
		<description><![CDATA[Like any good military unit, infectious bacteria have access to numerous weapons and efficient communication systems. But like soldiers in the field, they&#8217;re also susceptible to suicide bombers. Researchers have used the tools of synthetic biology to create an Escherichia coli cell that can infiltrate foreign bacteria and explode, killing off the pathogens along with [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/16/suicide-bombing-bacteria-could-fight-infections/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MS genetic discovery casts doubt on vein theory</title>
		<link>http://www.bioscreening.net/2011/08/11/ms-genetic-discovery-casts-doubt-on-vein-theory/</link>
		<comments>http://www.bioscreening.net/2011/08/11/ms-genetic-discovery-casts-doubt-on-vein-theory/#comments</comments>
		<pubDate>Thu, 11 Aug 2011 17:01:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1245</guid>
		<description><![CDATA[Scientists have discovered 29 new genetic variations linked to multiple sclerosis, with many involving genes relevant to the immune system – a finding that they say bolsters the theory that MS is a primarily an autoimmune disease. The new study, published Wednesday in the journal Nature, is the largest-ever study on the genetics of multiple [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/11/ms-genetic-discovery-casts-doubt-on-vein-theory/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists Claim Leukemia Stem Cell Signature Independently Predicts Poor Survival in AML</title>
		<link>http://www.bioscreening.net/2011/08/02/scientists-claim-leukemia-stem-cell-signature-independently-predicts-poor-survival-in-aml/</link>
		<comments>http://www.bioscreening.net/2011/08/02/scientists-claim-leukemia-stem-cell-signature-independently-predicts-poor-survival-in-aml/#comments</comments>
		<pubDate>Tue, 02 Aug 2011 15:27:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oncology Research]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1276</guid>
		<description><![CDATA[Research on samples from human acute myeloid leukemia (AML) patients has suggested that the a leukemia stem cell (LSC) gene expression profile can accurately be used to predict patient survival, even among AML patients with cytogenetically normal disease. An international team led by researchers at Ontario’s University Health Network and the University of Toronto’s Department [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/02/scientists-claim-leukemia-stem-cell-signature-independently-predicts-poor-survival-in-aml/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Smelly socks tested in Tanzania as way to prevent malaria</title>
		<link>http://www.bioscreening.net/2011/07/14/smelly-socks-tested-in-tanzania-as-way-to-prevent-malaria/</link>
		<comments>http://www.bioscreening.net/2011/07/14/smelly-socks-tested-in-tanzania-as-way-to-prevent-malaria/#comments</comments>
		<pubDate>Thu, 14 Jul 2011 15:49:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1213</guid>
		<description><![CDATA[In global public health, disease-fighting tools that are cheap, available and sustainable are the Holy Grail. It might be hard to top the one being tested in Tanzania as a way to prevent malaria: smelly socks. Experiments in three villages where people get about 350 bites a year from malaria-infected mosquitoes are using dirty socks [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/14/smelly-socks-tested-in-tanzania-as-way-to-prevent-malaria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stem cell research and use in veterinary medicine</title>
		<link>http://www.bioscreening.net/2011/07/07/stem-cell-research-and-use-in-veterinary-medicine/</link>
		<comments>http://www.bioscreening.net/2011/07/07/stem-cell-research-and-use-in-veterinary-medicine/#comments</comments>
		<pubDate>Thu, 07 Jul 2011 17:09:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[Stem Cell Research]]></category>
		<category><![CDATA[Veterinary Research]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1200</guid>
		<description><![CDATA[Stem cells show so much promise in human medicine. Cells that have the ability to become anything that the body needs is nothing short of a miracle. What is the role of stem cells in veterinary medicine? Do stem cells have a place? Many say they very much do. Stem cells are able to be [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/07/stem-cell-research-and-use-in-veterinary-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Who wants to live forever? Scientist sees aging cured</title>
		<link>http://www.bioscreening.net/2011/07/05/who-wants-to-live-forever-scientist-sees-aging-cured/</link>
		<comments>http://www.bioscreening.net/2011/07/05/who-wants-to-live-forever-scientist-sees-aging-cured/#comments</comments>
		<pubDate>Tue, 05 Jul 2011 15:56:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[Stem Cell Research]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1197</guid>
		<description><![CDATA[(Reuters) &#8211; If Aubrey de Grey&#8217;s predictions are right, the first person who will live to see their 150th birthday has already been born. And the first person to live for 1,000 years could be less than 20 years younger. A biomedical gerontologist and chief scientist of a foundation dedicated to longevity research, de Grey [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/07/05/who-wants-to-live-forever-scientist-sees-aging-cured/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Coffee buzz protects brain from Alzheimer&#8217;s</title>
		<link>http://www.bioscreening.net/2011/06/30/coffee-buzz-protects-brain-from-alzheimers/</link>
		<comments>http://www.bioscreening.net/2011/06/30/coffee-buzz-protects-brain-from-alzheimers/#comments</comments>
		<pubDate>Thu, 30 Jun 2011 15:00:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[R & D]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1190</guid>
		<description><![CDATA[For years we’ve been told that caffeinated coffee was bad for us. It’s unhealthy and addictive, doctors warned. But as vindication for all who stuck by their energizing elixir, a new study shows that guzzling caffeinated coffee may actually be good for our brains. In fact, it may help keep Alzheimer’s at bay. The study, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/30/coffee-buzz-protects-brain-from-alzheimers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hemophilia Is Target of Therapy on Genome</title>
		<link>http://www.bioscreening.net/2011/06/27/hemophilia-is-target-of-therapy-on-genome/</link>
		<comments>http://www.bioscreening.net/2011/06/27/hemophilia-is-target-of-therapy-on-genome/#comments</comments>
		<pubDate>Mon, 27 Jun 2011 15:13:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cell Analysis]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Research Projects]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1184</guid>
		<description><![CDATA[Researchers using a new technique for editing the genome of living cells have shown that they can cure hemophilia in mice, at least in principle, with a couple of injections that carry out the “cut” and “paste” operations needed to insert a corrective gene. This is the first time this genome-editing technique has succeeded in [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/06/27/hemophilia-is-target-of-therapy-on-genome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

